Sanofi (SNYNF) News Headlines

▮ More

Date

Headline

7/11/2019 7:12:00 AM Schrödinger Receives Milestone Payment From Sanofi Collaboration

7/11/2019 7:08:22 AM Schrödinger Receives Preclinical Milestone Payment From Sanofi

7/10/2019 1:28:49 AM Sanofi: FDA To Review Isatuximab As Potential Treatment For RRMM

7/10/2019 1:05:55 AM Sanofi Says FDA To Review Isatuximab For Relapsed/refractory Multiple Myeloma

7/8/2019 2:40:40 AM Swedish Orphan Biovitrum Says Interim Data Of Elocta Shared At ISTH

7/3/2019 2:24:26 AM BIOCORP Enters Talks With SANOFI To Use MallyaTM Connected Device With Sanofi’s Integrated Diabetes Care Platform

7/1/2019 10:25:39 AM Sanofi : EU Okays Libtayo For Advanced Cutaneous Squamous Cell Carcinoma

6/28/2019 7:11:07 AM Regeneron Pharma: CHMP Adopts Positive Opinion For Dupixent - Quick Facts

6/28/2019 7:01:29 AM Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent For Moderate-to-Severe Atopic Dermatitis In Adolescents

6/27/2019 1:23:21 AM Sanofi Says FDA To Review Meningococcal Vaccine Candidate MenQuadfi

6/27/2019 1:07:17 AM Sanofi : FDA To Review MenQuadfi, A Meningococcal Vaccine Candidate

6/21/2019 1:20:10 AM Regeneron Pharma: REGN3500 Meets Primary Endpoint In Phase 2 Study

6/21/2019 1:00:40 AM Regeneron, Sanofi: Phase 2 Proof-of-concept Trial Evaluating IL-33 Antibody REGN3500 Met Primary Endpoint

6/18/2019 10:14:58 AM Sanofi Partnering Google To Develop Virtual Healthcare Lab

6/18/2019 1:22:07 AM Sanofi, Google To Establish New Virtual Innovation Lab

6/7/2019 1:23:09 AM Sanofi Appoints Novartis Executive Paul Hudson As CEO

6/7/2019 1:04:25 AM Sanofi Says Paul Hudson To Succeed Olivier Brandicourt As CEO

6/2/2019 1:03:23 PM Sanofi Says Phase 3 Trial Of Isatuximab Combination Therapy Showed 40% Reduction In Risk Of Death For Patients With RRMM

5/24/2019 3:34:37 AM FDA Approves Dengvaxia, The Dengue Vaccine

5/7/2019 9:21:59 AM Regeneron & Sanofi: Dupixent Approved For Severe Asthma Indication In EU